Drug Shortage Report for FOSAVANCE
Report ID | 58261 |
Drug Identification Number | 02314940 |
Brand name | FOSAVANCE |
Common or Proper name | alendronate sodium / cholecalciferol tablets |
Company Name | ORGANON CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ALENDRONIC ACID VITAMIN D3 |
Strength(s) | 70MG 5600UNIT |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4TAB |
ATC code | M05BB |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-08-16 |
Estimated end date | 2018-08-16 |
Actual end date | 2018-08-16 |
Shortage status | Resolved |
Updated date | 2018-08-17 |
Company comments | Limited quantity will be available during that period. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-08-16 | English | Compare |
v2 | 2018-08-16 | French | Compare |
v3 | 2018-08-16 | English | Compare |
v4 | 2018-08-16 | English | Compare |
v5 | 2018-08-16 | French | Compare |
v6 | 2018-08-17 | English | Compare |
Showing 1 to 6 of 6